Physician profile
Jeffrey Levy
NPI 1720040306
$18,483.74
in general payments reported to CMS, 2019-2025
26 companies · $203 in 2025
The $203 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $10K · 2021: $3,605 · 2022: $1,466 · 2023: $451 · 2024: $2,435 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,559 · Food and Beverage: $1,531.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,559.23 |
| Food and Beverage | $1,530.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $11,639.05 | 2020-2024 | Arthrex |
| Stryker Corporation | $2,538.89 | 2021-2025 | Infinity, Prophecy, Prostep |
| Fortis Surgical, LLC | $1,884.97 | 2021-2025 | |
| Orthofix Medical, INC. | $1,427.40 | 2021 | |
| Bioventus LLC | $124.12 | 2024-2025 | Exogen Ultrasound Bone Healing System, Durolane |
| Nevro Corp. | $97.49 | 2021 | |
| Medical Device Business Services, INC. | $93.32 | 2023 | Na |
| Amgen INC. | $83.45 | 2019 | |
| Novastep INC. | $70.61 | 2022 | |
| Trilliant Surgical LLC. | $69.44 | 2023 | Minimally Invasive Bunion Plate, Left |
| Ucb, INC. | $60.02 | 2019 | |
| Medline Industries LP | $57.71 | 2023 | |
| Depuy Synthes Sales INC. | $55.91 | 2025 | Motoband |
| Restor3d, INC. | $51.08 | 2023 | |
| Paragon 28, INC. | $38.10 | 2023 | Apex 3d |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $32.70 | 2019 | |
| Acorda Therapeutics, INC | $28.57 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $21.37 | 2020 | |
| Jazz Pharmaceuticals INC. | $17.61 | 2019 | |
| Eisai INC. | $15.88 | 2019 | |
| Abbott Laboratories | $13.67 | 2019 | |
| Ferring Pharmaceuticals INC. | $13.14 | 2019 | |
| Fidia Pharma USA INC. | $13.00 | 2023 | Hymovis |
| Neurocrine Biosciences, INC. | $12.78 | 2019 | |
| Collegium Pharmaceutical, INC. | $12.33 | 2019 | |
| Zyla Life Sciences, INC. | $11.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.